Companies: 10,795·Total market cap: $144.5T
Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc.

APGENASDAQHealthcare● Active
$83.76
$-3.16(-3.63%)
Market Cap$5.2B
P/E Ratio
52W High$95.315
52W Low$34.34

Apogee Therapeutics, Inc. (APGE) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · APGE · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.21B$0.17B$0.07B$0.03B
G&A Expenses$0.07B$0.05B$0.02B$0.00B
Total Operating Expenses$0.28B$0.22B$0.09B$0.03B
Operating Income($0.29B)($0.22B)($0.09B)($0.03B)
Operating Margin %(computed)
Interest Income$0.03B$0.03B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.01B
Income Before Tax($0.26B)($0.18B)($0.08B)($0.04B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B
Net Income($0.26B)($0.18B)($0.08B)($0.04B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-4.22$-3.30$-1.66$-0.79
Wtd Avg Shares0.06B0.06B0.05B0.05B
EBITDA($0.28B)($0.22B)($0.07B)($0.04B)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Apogee Therapeutics, Inc. data

About Apogee Therapeutics, Inc. (APGE) Income Statement

Apogee Therapeutics, Inc. (APGE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, APGE reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.26B) — a net profit margin of —.

Frequently asked questions

APGE · 4 questions

Apogee Therapeutics, Inc. (APGE) reported revenue of $0.00B for 2025, down —% year-over-year.

APGE revenueAPGE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08